88516-84-1 Usage
Uses
Used in Pharmaceutical Industry:
(4-hydroxy-3-methoxy-5-nitro-phenyl)-acetic acid is used as a potential therapeutic agent for its antioxidant, anti-inflammatory, and analgesic properties, which may contribute to the treatment of various conditions and diseases.
Used in Neurological Disorder Treatment:
In the field of neurology, (4-hydroxy-3-methoxy-5-nitro-phenyl)-acetic acid is used as a potential treatment for certain neurological disorders due to its pharmacological properties that may help alleviate symptoms and improve patient outcomes.
Used in Anticancer Applications:
(4-hydroxy-3-methoxy-5-nitro-phenyl)-acetic acid is used as a potential agent for the suppression of tumor growth, with further research needed to understand its full therapeutic potential in oncology.
Used in Drug Development:
(4-hydroxy-3-methoxy-5-nitro-phenyl)-acetic acid is used in the development of new drugs, as its pharmacological properties may lead to the creation of novel medications for various medical applications, including pain management, inflammation reduction, and cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 88516-84-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,5,1 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 88516-84:
(7*8)+(6*8)+(5*5)+(4*1)+(3*6)+(2*8)+(1*4)=171
171 % 10 = 1
So 88516-84-1 is a valid CAS Registry Number.
88516-84-1Relevant academic research and scientific papers
Asymmetric, stereocontrolled total synthesis of paraherquamide A
Williams, Robert M.,Cao, Jianhua,Tsujishima, Hidekazu,Cox, Rhona J.
, p. 12172 - 12178 (2007/10/03)
The first total synthesis of paraherquamide A, a potent anthelmintic agent isolated from various Penicillium sp. with promising activity against drug-resistant intestinal parasites, is reported. Key steps in this asymmetric, stereocontrolled total synthesis include a new enantioselective synthesis of (α-alkylated-β-hydroxyproline derivatives to access the substituted proline nucleus and a highly diastereoselective intramolecular S N2′ cyclization to generate the core bicyclo[2.2.2]diazaoctane ring system.
